The Mobilise-D Public Webinar Series starts in February 2022 BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA John Linnell BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA Novartis job opportunity for analysis of wearable sensor data for Digital Mobility Outcomes BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA Norman Sutton BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA Episode 3: Making a difference in people’s lives – Silvia Del Din awarded a NUAcT Fellowship. BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA Episode 2: An INSIGHT into public engagement – Interview with PhD student Cameron Kirk BREAKING
NEWS
Read more
Why Mobilise-D matters – now more than ever! LATEST
VIDEO
More Videos
npj Digital Medicine Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes Polhemus et al. & Mobilise-D Other publications LATEST
PUBLICATION
SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed


📢 IT’S HAPPENING! 📢

We are pleased to announce that the Mobilise-D Public Webinar Series will start in February 2022. Save the dates and stay tuned for registration info👇

https://t.co/S4E7vWweGW https://t.co/mLcfyhrFZx
Mobilise_D photo

🌟 #MobilisedAdventCalendar Dec 3 🌟

Caruso et al. (2021). Analysis of the Accuracy of Ten Algorithms for Orientation Estimation Using Inertial and Magnetic Sensing under Optimal Conditions: One Size Does Not Fit All

https://t.co/5fcknIe40p https://t.co/OKoYfhhyTq
Mobilise_D photo

Latest News

The Mobilise-D Public Webinar Series starts in February 2022

We are proud to announce that Mobilise-D will launch a webinar series, starting in February 2022!  And we kick off with a bang, featuring a discussion about THE ALGORITHMS and Digital Mobility Outcomes (DMOs). Save the dates already now for all the webinars!   We have designed the first series of five webinars, twice a month (February…

Upcoming Events